These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3257898)

  • 1. Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2.
    Whiteside TL; Heo DS; Takagi S; Johnson JT; Iwatsuki S; Herberman RB
    Cancer Immunol Immunother; 1988; 26(1):1-10. PubMed ID: 3257898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.
    Heo DS; Whiteside TL; Johnson JT; Chen KN; Barnes EL; Herberman RB
    Cancer Res; 1987 Dec; 47(23):6353-62. PubMed ID: 3315186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and phenotypic analysis of tumor-infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in recombinant interleukin-2.
    Takagi S; Chen K; Schwarz R; Iwatsuki S; Herberman RB; Whiteside TL
    Cancer; 1989 Jan; 63(1):102-11. PubMed ID: 2642728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2.
    Yoo YK; Heo DS; Hata K; Van Thiel DH; Whiteside TL
    Gastroenterology; 1990 Feb; 98(2):259-68. PubMed ID: 2295382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocytes infiltrating human ovarian tumors. I. Role of Leu-19 (NKH1)-positive recombinant IL-2-activated cultures of lymphocytes infiltrating human ovarian tumors.
    Heo DS; Whiteside TL; Kanbour A; Herberman RB
    J Immunol; 1988 Jun; 140(11):4042-9. PubMed ID: 3286766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of novel anti-tumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes.
    Whiteside TL; Heo DS; Takagi S; Herberman RB
    Transplant Proc; 1988 Apr; 20(2):347-50. PubMed ID: 2834838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro generation and antitumor activity of adherent lymphokine-activated killer cells from the blood of patients with brain tumors.
    Whiteside TL; Wang YL; Selker RG; Herberman RB
    Cancer Res; 1988 Nov; 48(21):6069-75. PubMed ID: 2971433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes.
    Wang YL; Si LS; Kanbour A; Herberman RB; Whiteside TL
    Cancer Res; 1989 Nov; 49(21):5979-85. PubMed ID: 2507139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumor effector cells in recombinant IL-2 activated tumor infiltrating lymphocytes from human solid cancers].
    Ishii S; Shiiba K; Ebina N; Matsuno S
    Nihon Geka Gakkai Zasshi; 1993 Mar; 94(3):213-24. PubMed ID: 7686244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Functional and phenotypic analysis of tumor infiltrating lymphocytes derived from solid tumors and effusion associated lymphocytes in malignant ascites cultured in recombinant interleukin 2].
    Itoh K; Shiiba K; Ebina N; Anzai R; Ouchi A; Matsuno S
    Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):781-90. PubMed ID: 8377752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.
    Finke JH; Rayman P; Alexander J; Edinger M; Tubbs RR; Connelly R; Pontes E; Bukowski R
    Cancer Res; 1990 Apr; 50(8):2363-70. PubMed ID: 2107973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysis by interleukin 2-stimulated tumor-infiltrating lymphocytes of autologous and allogeneic tumor target cells.
    Radrizzani M; Gambacorti-Passerini C; Parmiani G; Fossati G
    Cancer Immunol Immunother; 1989; 28(1):67-73. PubMed ID: 2462469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
    Miescher S; Whiteside TL; Moretta L; von Fliedner V
    J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypical and functional differences of tumor-infiltrating lymphocytes from human colorectal cancers induced by costimulation with rIL-2 and rIL-4 in vitro.
    Keller H; Wimmenauer S; Rahner S; Von Kleist S; Farthmann EH
    Anticancer Res; 1996; 16(6B):3565-70. PubMed ID: 9042222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.
    Itoh K; Tilden AB; Balch CM
    Cancer Res; 1986 Jun; 46(6):3011-7. PubMed ID: 3486040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): activation by autologous tumour cell alone.
    Katano M; Nagumo F; Kubota E; Yamamoto H; Matsuo T; Hisatsugu T; Tadano J
    Biotherapy; 1993; 6(1):25-32. PubMed ID: 8507542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors.
    Shimizu Y; Iwatsuki S; Herberman RB; Whiteside TL
    Cancer Immunol Immunother; 1991; 32(5):280-8. PubMed ID: 1847844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIL from renal-cell carcinoma: restimulation with tumor influences proliferation and cytolytic activity.
    Alexander J; Rayman P; Edinger M; Connelly R; Tubbs R; Bukowski R; Pontes E; Finke J
    Int J Cancer; 1990 Jan; 45(1):119-24. PubMed ID: 2298495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity.
    Belldegrun A; Muul LM; Rosenberg SA
    Cancer Res; 1988 Jan; 48(1):206-14. PubMed ID: 3257161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.